TGFB1 and prostate carcinoma: We treated the human prostate cancer cell lines PacMetUT1, PC-3, and DU145 with TGF-β1, RER, HTS, or NeuAb alone, or TGF-β1 in combination with RER, HTS, or NeuAb for 2 hrs.